These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
259 related articles for article (PubMed ID: 23216782)
1. Hepatic resection for hepatocellular carcinoma in patients with Child-Pugh's A cirrhosis: is clinical evidence of portal hypertension a contraindication? Santambrogio R; Kluger MD; Costa M; Belli A; Barabino M; Laurent A; Opocher E; Azoulay D; Cherqui D HPB (Oxford); 2013 Jan; 15(1):78-84. PubMed ID: 23216782 [TBL] [Abstract][Full Text] [Related]
2. Neither multiple tumors nor portal hypertension are surgical contraindications for hepatocellular carcinoma. Ishizawa T; Hasegawa K; Aoki T; Takahashi M; Inoue Y; Sano K; Imamura H; Sugawara Y; Kokudo N; Makuuchi M Gastroenterology; 2008 Jun; 134(7):1908-16. PubMed ID: 18549877 [TBL] [Abstract][Full Text] [Related]
3. Radiofrequency ablation plus devascularization is the preferred treatment of hepatocellular carcinoma with esophageal varices. Zhang K; Jiang L; Jia Z; Zhang Y; He R; Ding Z; Mu Y Dig Dis Sci; 2015 May; 60(5):1490-501. PubMed ID: 25431044 [TBL] [Abstract][Full Text] [Related]
4. Hepatocellular carcinoma in cirrhotic patients with portal hypertension: is liver resection always contraindicated? Ruzzenente A; Valdegamberi A; Campagnaro T; Conci S; Pachera S; Iacono C; Guglielmi A World J Gastroenterol; 2011 Dec; 17(46):5083-8. PubMed ID: 22171142 [TBL] [Abstract][Full Text] [Related]
5. Risk factors and surgical outcomes for spontaneous rupture of BCLC stages A and B hepatocellular carcinoma: a case-control study. Li J; Huang L; Liu CF; Cao J; Yan JJ; Xu F; Wu MC; Yan YQ World J Gastroenterol; 2014 Jul; 20(27):9121-7. PubMed ID: 25083085 [TBL] [Abstract][Full Text] [Related]
7. Development of a nomogram to predict outcome after liver resection for hepatocellular carcinoma in Child-Pugh B cirrhosis. Berardi G; Morise Z; Sposito C; Igarashi K; Panetta V; Simonelli I; Kim S; Goh BKP; Kubo S; Tanaka S; Takeda Y; Ettorre GM; Wilson GC; Cimino M; Chan CY; Torzilli G; Cheung TT; Kaneko H; Mazzaferro V; Geller DA; Han HS; Kanazawa A; Wakabayashi G; Troisi RI J Hepatol; 2020 Jan; 72(1):75-84. PubMed ID: 31499131 [TBL] [Abstract][Full Text] [Related]
8. Morbidity of hepatic resection for intermediate and advanced hepatocellular carcinoma. Renner P; Schuhbaum J; Kroemer A; Zeman F; Loss M; Lang SA; Geissler EK; Schlitt HJ; Farkas SA Langenbecks Arch Surg; 2016 Feb; 401(1):43-53. PubMed ID: 26627084 [TBL] [Abstract][Full Text] [Related]
9. Is portal hypertension a contraindication to hepatic resection? Cucchetti A; Ercolani G; Vivarelli M; Cescon M; Ravaioli M; Ramacciato G; Grazi GL; Pinna AD Ann Surg; 2009 Dec; 250(6):922-8. PubMed ID: 19855258 [TBL] [Abstract][Full Text] [Related]
10. External validation of a simplified BCLC staging system for early hepatocellular carcinoma. Santambrogio R; Salceda J; Costa M; Kluger MD; Barabino M; Laurent A; Opocher E; Azoulay D; Cherqui D Eur J Surg Oncol; 2013 Aug; 39(8):850-7. PubMed ID: 23726257 [TBL] [Abstract][Full Text] [Related]
11. Hepatocellular carcinoma: surgical perspectives beyond the barcelona clinic liver cancer recommendations. Guglielmi A; Ruzzenente A; Conci S; Valdegamberi A; Vitali M; Bertuzzo F; De Angelis M; Mantovani G; Iacono C World J Gastroenterol; 2014 Jun; 20(24):7525-33. PubMed ID: 24976693 [TBL] [Abstract][Full Text] [Related]
12. Liver surgery in cirrhosis and portal hypertension. Hackl C; Schlitt HJ; Renner P; Lang SA World J Gastroenterol; 2016 Mar; 22(9):2725-35. PubMed ID: 26973411 [TBL] [Abstract][Full Text] [Related]
13. Influence of clinically significant portal hypertension on survival after hepatic resection for hepatocellular carcinoma in cirrhotic patients. Giannini EG; Savarino V; Farinati F; Ciccarese F; Rapaccini G; Marco MD; Benvegnù L; Zoli M; Borzio F; Caturelli E; Chiaramonte M; Trevisani F; Liver Int; 2013 Nov; 33(10):1594-600. PubMed ID: 23654354 [TBL] [Abstract][Full Text] [Related]
14. Preoperative predictors of short-term survival after hepatectomy for multinodular hepatocellular carcinoma. Zhao WC; Zhang HB; Yang N; Fu Y; Qian W; Chen BD; Fan LF; Yang GS World J Gastroenterol; 2012 Jul; 18(25):3272-81. PubMed ID: 22783052 [TBL] [Abstract][Full Text] [Related]
15. A snapshot of the effective indications and results of surgery for hepatocellular carcinoma in tertiary referral centers: is it adherent to the EASL/AASLD recommendations?: an observational study of the HCC East-West study group. Torzilli G; Belghiti J; Kokudo N; Takayama T; Capussotti L; Nuzzo G; Vauthey JN; Choti MA; De Santibanes E; Donadon M; Morenghi E; Makuuchi M Ann Surg; 2013 May; 257(5):929-37. PubMed ID: 23426336 [TBL] [Abstract][Full Text] [Related]
18. Minor versus major hepatic resection for small hepatocellular carcinoma (HCC) in cirrhotic patients: a 20-year experience. Dahiya D; Wu TJ; Lee CF; Chan KM; Lee WC; Chen MF Surgery; 2010 May; 147(5):676-85. PubMed ID: 20004441 [TBL] [Abstract][Full Text] [Related]
19. Survival outcomes of hepatectomy for stage B Hepatocellular carcinoma in the BCLC classification. Kamiyama T; Orimo T; Wakayama K; Shimada S; Nagatsu A; Yokoo H; Kamachi H; Yamashita K; Shimamura T; Taketomi A World J Surg Oncol; 2017 Aug; 15(1):156. PubMed ID: 28830473 [TBL] [Abstract][Full Text] [Related]
20. High platelet count as a poor prognostic factor for liver cancer patients without cirrhosis. Midorikawa Y; Takayama T; Higaki T; Aramaki O; Teramoto K; Yoshida N; Tsuji S; Kanda T; Moriyama M Biosci Trends; 2020 Nov; 14(5):368-375. PubMed ID: 32713867 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]